According to Nova One Advisor, the global protein
purification and isolation market size is expected to be worth around 33.02
billion by 2034, increasing from USD 13.13 billion in 2025, representing a
healthy CAGR of 10.79 % from 2025 to 2034.
The protein purification and isolation market are expanding
due to purified and isolated proteins are utilized in various fields such as biochemical
assays, drug discovery, enzymology, and the manufacturing of
therapeutic agents like antibodies and vaccines.
Proteins are considered significant biomolecules that
perform different important functions in living organisms. This imaging
technology is significant for structural biology studies, where it allows
protein crystallization and X-ray crystallography or Nuclear
Magnetic Resonance (NMR) spectroscopy. This is an integral component of
advanced biomedical research, with numerous applications in drug development,
basic research, and diagnostics.
• For Instance, In June 2025, QIAGEN and GENCURIX, Inc.
announced a new partnership to develop oncology assays for use on the
QIAcuityDx platform, a high-performance digital PCR system designed for
clinical diagnostics.
The Complete Study is Now Available for Immediate Access
| Download the Sample Pages of this Report@ https://www.novaoneadvisor.com/report/sample/1404
Major Technology and Its Advantages in Protein
Purification
Technology
Example
Preparative Chromatographic
Technique
High
Resolution and Separation Power
Versatility
in Separation Mechanisms
High Capacity
and Scalability
Â
Ultrafiltration
High
Separation Efficiency
Suitability
for Heat-Sensitive Substances
Simple and
Efficient Process
Precipitation
Cost-Effectiveness
High Yield
Electrophoresis
 Separation
by Size and Charge
High
Resolution and Separation Power
Immumnobltting
Specificity
Size
Determination
Versatility
Dialysis and
Diafiltration
Simple and
Cost-effective
Preserves
Protein Integrity
Centrifugation
Speed and
Efficiency
Versatility
Removal of
Cell Debris
Â
Protein Purification and Isolation Market Highlights:
• North America dominated the global protein purification
and isolation market with the largest share in 2024.
• Asia Pacific is expected to grow at the fastest CAGR
during the forecast period.
• By product, the monoclonal antibodies segment dominated
the market with the largest share in 2024.
• By product, the gene therapy products segment is expected
to show the fastest growth over the forecast period.
• By end use, the pharmaceutical and biotechnology companies
segment accounted for the biggest market share in 2024.
• By end use, the CMOs & CROs segment is expected to
register the fastest growth during the forecast period.
Market Overview and Industry Potential
The protein purification and isolation market are expanding
due to this is a process in biochemistry and molecular biology that involves
isolating an exact protein from a complex mixture, which may be sourced from
cells, tissues, or other biological materials. It is applied to develop
reagents like antibodies and enzymes that are used as significant molecular
biology tools for a complete understanding of cellular processes. Purified
proteins are used to manufacture assays and tests for diseases.
• For Instance, In January 2025, Iktos, a leader in Artificial
Intelligence (AI) and Robotics for drug design, and Cube Biotech, a
pioneer in membrane protein production and purification technologies, today
announced a strategic collaboration to discover novel small molecule agonists
of the Amylin Receptor.
The main goal is to gain an extremely pure form of the
desired protein while eliminating impurities efficiently. Purified proteins
play a key role in understanding particular biomolecules’ structure,
regulation, and function. It is significantly used in the biotechnology and
pharmaceutical industries for producing therapeutic drugs, vaccines, and
recombinant proteins.
Latest Trends of the Market
• In September 2024, the Union Cabinet approved the
Biotechnology Research Innovation and Entrepreneurship Development (Bio-RIDE)
scheme to support advanced research and development in biotechnology
• In April 2025, the iBRIC-Institute for Stem Cell Science
and Regenerative Medicine announced that the Hon’ble Union Minister of State
for Science and Technology (I/C), Dr. Jitendra Singh, visited BRIC-inStem.
BRIC-inStem is the first national research institute dedicated to studying stem
cells and regenerative medicine, emphasising translating scientific research
into technologies that serve society.
Recent Advancement in Technology: Market’s Largest
Potential
By using progressive techniques and sophisticated analytical
procedures, researchers isolate and thoroughly characterize proteins. By
developing these techniques, scientists comprehensively describe purified
proteins, ensuring their appropriateness for different applications in
therapeutics, diagnostics, and research. These are the significant steps in
biotechnology, pharmaceutical
development, and research, allowing the manufacturing of high-purity
proteins for various applications.
Immediate Delivery Available | Buy This Premium Research https://www.novaoneadvisor.com/report/checkout/1404
Report Scope of Protein Purification and
Isolation Market
Report Coverage
Details
Market Size in 2025
USD 13.13 Billion
Market Size by 2034
USD 33.02 Billion
Growth Rate From 2025
to 2034
CAGR of 10.79%
Base Year
2024
Forecast Period
2025-2034
Segments Covered
Product, Application,
Technology, End use, Region
Market Analysis
(Terms Used)
Value (US$
Million/Billion) or (Volume/Units)
Regional scope
North America;
Europe; Asia Pacific; Latin America; MEA
Key Companies Profiled
Agilent Technologies,
Inc., Bio-Rad Laboratories, Inc., Cube Biotech GmbH, Danaher, Merck KGaA,
Norgen Biotek Corp., Promega Corporation, QIAGEN, Takara Bio. Inc., Thermo
Fisher Scientific, Inc.
Â
Protein Purification and Isolation Market Segmentation
Analysis:
By Product Analysis:
The consumables
segment dominates in the protein
purification and isolation market, as they are vital for maintaining
the sterility of medical processes, thereby avoiding infections and ensuring
patient care. Consumables play a critical role in patient safety and in
protecting staff. It is important to maintain an advanced supply chain for
healthcare consumables.
On the other hand, the instruments segment is expected to
grow significantly during the forecast period, as it plays a significant role
in research and development in industries such as medicine and environmental
science. Automated equipment ensures that medical products are handled and
packaged safely and constantly. It has huge potential to manufacture novel
diagnostics, vaccines, drugs, and other medical countermeasures required to
identify, prevent, and manage infectious diseases.
By Technology Analysis:
The chromatography
segment dominated the market in 2024, as it is the most powerful
technique for protein purification and identification. It enables the
separation of proteins based on their exclusive physicochemical properties.
Chromatography is a vital tool in protein purification, providing exact and
effective separation.
Its varied techniques cater to diverse protein
characteristics and purification requirements, making it indispensable for
modern scientific research and developing therapeutic applications. Chromatography
in protein purification is not only related to isolating proteins but also to
maintaining their biological activity.
On the other hand, the electrophoresis
segment is expected to grow at the fastest CAGR in the market during the
forecast period, as electrophoresis is a standard laboratory technique through
which charged protein molecules are transported through a solvent by an
electrical field.
Proteins and nucleic acids may be isolated by
electrophoresis, which is an easy, fast, and sensitive analytical tool. Protein
electrophoresis is applied to discrete proteins based on their size and charge.
By Application Analysis:
The protein-protein interaction segment dominated the market
in 2024, as protein-protein interaction plays a key role in predicting the
protein function of the target protein and the drug ability of molecules. The
commonality of genes and proteins results in phenotype functions as a set of
interactions. Protein-protein interactions are of supreme importance for
understanding the molecular mechanisms of proteins, clarifying cellular
processes, and progressing drug discovery.
On the other hand, the drug screening segment is expected to
register the fastest growth during the forecast period as advanced purification
and identification processes improve the yield and activity of proteins,
enabling breakthroughs in healthcare research and industrial applications.
Constant advancement in these methodologies allows more
efficient, affordable, and scalable production of advanced-quality proteins,
growing innovation and discovery in many scientific domains.
By End Use Analysis:
The academic
and research institutes segment captured the largest market share in
2024 by using purified protein. Researchers study its biochemical
characteristics, like enzyme activity, structural conformation, and binding
affinity. This data is valuable for elucidating metabolic pathways,
understanding disease mechanisms, and designing drugs that modulate the
functions of proteins.
The hospitals segment is expected to show the fastest growth
during the forecast period, as protein purification and identification
technologies dramatically lower operational costs in healthcare entities by
optimizing resource use. By engaging automated purification systems,
laboratories lower the requirement for widespread manual intervention and
reduce errors, resulting in significant savings.
By Regional Insights
North America dominated the protein purification and
isolation market in 2024 due to the presence of a strong biopharmaceutical
industry with a growing demand for ground-breaking treatments and a strong
commitment to addressing chronic diseases. North America is a significant
player in shaping the future of drug development because it has advanced
healthcare facilities. There are over 5,000 pharmaceutical companies in North
America that require advanced protein purification processes, which contributes
to the growth of the market growth.
• For Instance, In December 2024, Repligen Corporation
announced the launch of AVIPure dsRNA Clear OPUS columns, a ground-breaking
solution designed to simplify and improve the production of mRNA therapeutics
and vaccines. This novel affinity chromatography offers marries Repligen’s
breakthrough dsRNA purification resin with its flagship OPUS pre-packed
columns. The AVIPure dsRNA Clear resin offers unmatched performance in the removal
of double-stranded RNA (dsRNA) impurities from transcribed RNA.
U.S. Protein Purification and Isolation Market Trends:
The U.S. is the largest R&D spender with a focus on
keeping its competitive edge. In 2025, it will spend $193.39 billion on R&D
services, so it will increase the demand for purification technology. Growing
large-scale investments in novel infrastructure represent the greatest
potential to enhance healthcare services, driving the growth of the market.
Why Asia Pacific is the Fastest Growing in the Human DNA
Vaccine Market?
The Asia Pacific healthcare sector has huge potential for
growth, and the presence of major biotech companies that drive innovation.
Increasing incidences of genetic disorders, cardiovascular diseases, and cancer
create a critical requirement for precise, personalized treatment modalities,
which drives the demand for purified protein use in diagnostics and targeted
therapies.
Protein Purification and Isolation Market Companies:
• Agilent
Technologies, Inc.
• Bio-Rad
Laboratories, Inc.
• Cube Biotech GmbH
• Danaher
• Merck KGaA
• Norgen Biotek Corp.
• Promega Corporation
• QIAGEN
• Takara Bio. Inc.
• Thermo
Fisher Scientific, Inc.
What is Going Around the Globe?
• In June 2024, Ecolab’s Purolite resin business launched
DurA Cycle, a protein A chromatography resin for large-scale purification
processes, together with Repligen
• In February 2024, Purolite, an Ecolab company and a
manufacturer of synthetic and agarose-based bioprocessing resins, and Repligen
announced that they have commercially launched Praesto CH1, a new 70 μm
(micron) agarose-based affinity resin designed. The resin is designed to purify
specialized monoclonal antibodies like bispecifics and recombinant antibody
fragments.
You can place an order or ask any questions, please feel
free to contact at sales@novaoneadvisor.com
 | +1 804 441 9344
Related Report
⬧︎Acne
Medication Market- https://www.novaoneadvisor.com/report/acne-medication-market
⬧︎Advanced
Wound Care and Closure Market- https://www.novaoneadvisor.com/report/advanced-wound-care-and-closure-market
⬧︎Analgesics
Market- https://www.novaoneadvisor.com/report/analgesics-market
⬧︎Anti-counterfeit
Packaging Market- https://www.novaoneadvisor.com/report/anti-counterfeit-packaging-market
⬧︎Antiemetics
Drugs Market- https://www.novaoneadvisor.com/report/antiemetics-drugs-market
⬧︎Anti-Inflammatory
Therapeutics Market- https://www.novaoneadvisor.com/report/anti-inflammatory-therapeutics-market
⬧︎Asthma
and COPD Drugs Market- https://www.novaoneadvisor.com/report/asthma-and-copd-drugs-market
⬧︎Automated
Compounding System Market- https://www.novaoneadvisor.com/report/automated-compounding-system-market
⬧︎Automated
Microscopy Market- https://www.novaoneadvisor.com/report/automated-microscopy-market
⬧︎Biosimilars
Market- https://www.novaoneadvisor.com/report/biosimilars-market
Segments Covered in the Report
This report forecasts revenue growth at country levels and
provides an analysis of the latest industry trends in each of the sub-segments
from 2021 to 2034. For this study, Nova one advisor, Inc. has segmented the
global protein purification and isolation market
By Product
• Instruments
• Consumables
º Kits
º Reagents
º Columns
º Magnetic Beads
º Resins
º Others
By Technology
• Ultrafiltration
• Precipitation
• Chromatography
º Ion Exchange Chromatography
º Affinity Chromatography
º Reversed-phase Chromatography
º Size Exclusion Chromatography
º Hydrophobic Interaction
Chromatography
• Electrophoresis
º Gel Electrophoresis
º Isoelectric Focusing
º Capillary Electrophoresis
• Western Blotting
• Others
By Application
• Drug Screening
• Biomarker Discovery
• Protein-protein Interaction Studies
• Diagnostics
By End-use
• Academic And Research Institutes
• Hospitals
• Pharmaceutical And Biotechnological Companies
• CROs
By Regional
• North America
• Europe
• Asia Pacific
• Latin America
• Middle East and Africa (MEA)
Immediate Delivery Available | Buy This Premium Research https://www.novaoneadvisor.com/report/checkout/1404
About-Us
Nova One Advisor is a global leader in market
intelligence and strategic consulting, committed to delivering deep,
data-driven insights that power innovation and transformation across
industries. With a sharp focus on the evolving landscape of life sciences, we
specialize in navigating the complexities of cell and gene therapy, drug
development, and the oncology market, enabling our clients to lead in some of
the most revolutionary and high-impact areas of healthcare.
Our expertise spans the entire biotech and
pharmaceutical value chain, empowering startups, global enterprises, investors,
and research institutions that are pioneering the next generation of therapies
in regenerative medicine, oncology, and precision medicine.
Web: https://www.novaoneadvisor.com/
Contact Us
USA:Â +1 804 420 9370
Email: sales@novaoneadvisor.com
For Latest Update Follow Us: LinkedIn